Protocol Ledger

NCT04205968 · Phase II · RECRUITING

Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers

Interventional Phase II clinical trial protocol NCT04205968 sponsored by SWOG Cancer Research Network in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2020-06-01 Enrollment: 94 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT04205968
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)94 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT04205968
Protocol FieldVerified Registry Value
NCT IdentifierNCT04205968
Consolidated Lead SponsorSWOG Cancer Research Network
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase II
Overall Recruitment StatusRECRUITING
Registered Enrollment94 participants (ESTIMATED)
Registered Start Date2020-06-01
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI